Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 151

Sort by

Sort Order Select

Journal Articles

Genetics of osteonecrosis in pediatric acute lymphoblastic leukemia and general populations

Wenjian Yang, Meenakshi Devidas, Yiwei Liu, Colton Smith, Yunfeng Dai, Naomi Winick, Stephen P. Hunger, Mignon L. Loh, Elizabeth A. Raetz, Eric C. Larsen, William L. Carroll, Stuart S. Winter, Kimberly P. Dunsmore, Leonard A. Mattano, Jr, Mary V. Relling, Seth E. Karol

Blood (2021) 137 (11): 1550–1552.

https://doi.org/10.1182/blood.2020008471

Published: 2021

Includes: Supplemental data

Journal Articles

CELL-Derived Microparticles and Sickle CELL Disease Chronic Vasculopathy in Sub-Saharan Africa

Abdoul Karim Dembele, MD, Claudine Lapoumeroulie, PhD, Mor Diaw, PhD, Oumar Tessougué, MD, Lucile Offredo, MS, Dapa Aly Diallo, MD, Saliou Diop, MD MSc, Jacques Elion, MD PhD, Yves Colin Aronovicz, Pierre Louis Tharaux, MD PhD, Xavier Jouven, MD PhD, Marc Romana, PhD, Brigitte Ranque, MD PhD, Caroline Le Van Kim, PhD

Blood (2019) 134 (Supplement_1): 3568.

https://doi.org/10.1182/blood-2019-121334

Published: 2019

Journal Articles

Lack of Benefit of Extended Vincristine and Dexamethasone Pulses during Maintenance Treatment of Childhood Acute Lymphoblastic Leukemia: A Multicenter Randomized Controlled Study of Chinese Children Cancer Group (CCCG)-ALL-2015

Blood (2019) 134 (Supplement_1): 2576.

https://doi.org/10.1182/blood-2019-128523

Published: 2019

Journal Articles

Polymorphisms in Inflammatory Genes Modulate the Occurrence of Clinical Complications in Patients with Sickle Cell Disease

Blood (2019) 134 (Supplement_1): 4825.

https://doi.org/10.1182/blood-2019-124218

Published: 2019

Journal Articles

Treatment of Newly Diagnosed Moderate or Severe Chronic Graft-Versus-Host Disease with Prednisone and Everolimus (PredEver first): A Prospective Multicenter Phase IIa Study

Francis Ayuketang Ayuk, MD, Eva Maria Wagner, MD, Daniel Wolff, MD, Stephanie von Harsdorf, MD, Christian Koenecke, MD, Herbert G. Sayer, MD PhD, Nicolaus Kroeger, MD

Blood (2019) 134 (Supplement_1): 4523.

https://doi.org/10.1182/blood-2019-129801

Published: 2019

Journal Articles

Genetic Ancestry and Skeletal Toxicities Among Childhood Acute Lymphoblastic Leukemia Patients in the DFCI 05-001 Cohort

Qianqian Zhu, PhD, Song Yao, PhD, Peter D Cole, MD, Justine M. Kahn, MD MS, Marian H. Harris, MD PhD, Emily Schiller, MS, Uma Athale, MDMBBS,MSc, Luis A. Clavell, MD, Caroline Laverdiere, MD FRCPC, Jean-Marie Leclerc, MDFRCPC, Bruno Michon, MD FRCPC, Marshall A. Schorin, MD, Jennifer J.G. Welch, MD, Stephen E. Sallan, MD, Lewis B. Silverman, MD, Kara M. Kelly, MD

Blood (2019) 134 (Supplement_1): 3811.

https://doi.org/10.1182/blood-2019-126814

Published: 2019

Journal Articles

Studying the Determinant of Sickle Cell Disease Vasculopathy in Sub-Saharan Africa : The Biocadre Study

Brigitte Ranque, Abdoul Karim Dembele, MD, Mor Diaw, PhD, Claudine Lapoumeroulie, PhD, Lucile Offredo, MS, Dapa Aly Diallo, MD, Diop Saliou, MD, Yves Colin Aronovicz, PhD, Olivier Blanc Brude, PhD, Philippe Connes, PhD, Pierre-Louis Tharaux, MD PhD, Marc Romana, PhD, Xavier Jouven, MD PhD, Caroline Le Van Kim, PhD

Blood (2019) 134 (Supplement_1): 2310.

https://doi.org/10.1182/blood-2019-126713

Published: 2019

Journal Articles

Hydroxyurea Exposure throughout Pregnancy in Patients with Sickle-Cell Disease : 4 Case Reports from European Non-Interventional, Multicentric, Prospective Escort-HU Study

Justine Gellen-Dautremer, MD, Sylvain Le Jeune, MD, Marie-Catherine Receveur, MD, Elena Foïs, MD

Blood (2019) 134 (Supplement_1): 1027.

https://doi.org/10.1182/blood-2019-126529

Published: 2019

Journal Articles

Up-Regulation of Mir-21 and Mir-130a and Serum Leptin Levels on Leg Ulcers Development in Sickle Cell Anemia

Thais Helena Chaves Batista, Rodrigo Marcionilo Santana, Marcondes José de Vasconcelos Costa Sobreira, BSc, Gabriela da Silva Arcanjo, BSc, Diego Arruda Falcao, PhD, Diego A Pereira-Martins, MD, Aderson da Silva Araujo, MD PhD, Fernando Ferreira Costa, MD PhD, Mario José Abdalla Saad, PhD MD, Bruno de Melo Carvalho, PhD, Luydson Richardson Silva Vasconcelos, PhD, Antonio R. Lucena-Araujo, PhD, Marcos Andre Cavalcanti Bezerra, PhD

Blood (2019) 134 (Supplement_1): 975.

https://doi.org/10.1182/blood-2019-132043

Published: 2019

Journal Articles

Hypertension is a modifiable risk factor for osteonecrosis in acute lymphoblastic leukemia

Laura J. Janke, Sara L. Van Driest, Mary V. Portera, Ravi V. Atreya, Joshua C. Denny, Deqing Pei, Cheng Cheng, Sue C. Kaste, Hiroto Inaba, Sima Jeha, Ching-Hon Pui, Mary V. Relling, Seth E. Karol

Blood (2019) 134 (12): 983–986.

https://doi.org/10.1182/blood.2019000006

Published: 2019

Includes: Supplemental data

Journal Articles

Zoledronic Acid Reduces Osteonecrosis and Anti-Leukemic Efficacy in Murine Models of Acute Lymphoblastic Leukemia Therapy

Laura Janke, DVM, PhD, Jieun Kim, PhD, David Jenkins, BS, Monique A Payton, BS, Mary V Relling, PharmD, Seth E Karol, MD

Blood (2018) 132 (Supplement 1): 4029.

https://doi.org/10.1182/blood-2018-99-112941

Published: 2018

Journal Articles

Osteonecrosis in Pediatric Patients with Acute Lymphoblastic Leukemia (ALL): A Single-Center Cohort Analysis

Erica Brivio, MD, Andrea Davide Cossio, MD, Davide Borra, MD, Antonella Colombini, MD, Giulia Prunotto, MD, Daniela Silvestri, Adriana Balduzzi, MD

Blood (2018) 132 (Supplement 1): 2663.

https://doi.org/10.1182/blood-2018-99-114910

Published: 2018

Journal Articles

The Effect of Asparaginase on Serum Triglycerides during Therapy for Acute Lymphoblastic Leukemia

Emily R Finch, PhD, Colton A Smith, PhD, Wenjian Yang, PhD, Nancy M Kornegay, John C Panetta, PhD, Kristine R Crews, PharmD, Alejandro R Molinelli, PhD, Cheng Cheng, PhD, Deqing Pei, MS, Laura B. Ramsey, PhD, Seth E Karol, MD, Hiroto Inaba, MD, John T. Sandlund, MD, Monika Metzger, MD, William E. Evans, PharmD, Sima Jeha, MD, Ching-Hon Pui, MD, Mary V Relling, PharmD

Blood (2018) 132 (Supplement 1): 2665.

https://doi.org/10.1182/blood-2018-99-117093

Published: 2018

Journal Articles

microRNA and Severity of Sickle Cell Anemia

Thaís Priscila Biassi, MSc, Elvira Maria Guerra-Shinohara, PhD, Patrícia Natália Silva Moretti, PhD, Valeria de Freitas Dutra, MD, Ana Carolina Cabañas-Pedro, MSc, Grazielle Mecabo, PhD, Gisele W. B. Colleoni, PhD, Maria Stella Figueiredo, MD PhD

Blood (2018) 132 (Supplement 1): 3647.

https://doi.org/10.1182/blood-2018-99-115315

Published: 2018

Journal Articles

Amsacrine, Etoposide and Methylprednisolone As Part of the Therapy Intensification in Children with Acute Lymphoblastic Leukemia: A Retrospective Analysis in the Trial Coall 08-09

Gabriele Escherich, Katharina Wos, MD, Franziska Schramm, MD, Martin A. Horstmann, MD

Blood (2018) 132 (Supplement 1): 5168.

https://doi.org/10.1182/blood-2018-99-112623

Published: 2018

Journal Articles

Long-Term Follow-up of SWOG S0816: Response-Adapted Therapy for Stage III/IV Hodgkin Lymphoma Demonstrates Limitations of PET-Adapted Approach

Deborah M. Stephens, Hongli Li, MS, Heiko Schoder, MD, David J. Straus, MD, Craig H. Moskowitz, MD, Michael L. Leblanc, PhD, Lisa M. Rimsza, MD, Nancy L. Bartlett, MD, Andrew M. Evens, DO, MSc, Ann S. LaCasce, MD MSc, Paul Barr, MD, Michael V. Knopp, Eric D. Hsi, MD, John P. Leonard, MD, Brad S Kahl, MD, Sonali M. Smith, MD, Jonathan W. Friedberg, MD

Blood (2018) 132 (Supplement 1): 929.

https://doi.org/10.1182/blood-2018-99-113034

Published: 2018

Journal Articles

Characterizing a Population with Severe Manifestations of Sickle Cell Disease Using U.S. Real-World Evidence

Clark Paramore, MPH, Amanda Kong, MPH, Sachiyo Minegishi, Weiliang Shi, PhD

Blood (2018) 132 (Supplement 1): 4811.

https://doi.org/10.1182/blood-2018-99-118874

Published: 2018

Journal Articles

Outcomes of Hip Arthroplasty in Sickle Cell Disease: A 20 Year Retrospective Review

Karina D'Souza, MD, Ayanna Baptiste, MBBS, Jai Jung, MD, Rita Bellevue, MD

Blood (2018) 132 (Supplement 1): 2286.

https://doi.org/10.1182/blood-2018-99-119539

Published: 2018

Journal Articles

Validation of Sickle Cell Disease Severity Score in a Cohort of Hemoglobin SC Disease Patients

Rebecca Marie Rosart, MD, Olivia A. Pestrin, George A. Tomlinson, PhD BSc, MSc, Richard Ward, MBBS, MRCP, Jacob Pendergrast, MD FRCPC, Andrew Binding, MD MSc, FRCPC, Kevin H. M. Kuo, MD MSc, FRCPC

Blood (2018) 132 (Supplement 1): 2287.

https://doi.org/10.1182/blood-2018-99-111364

Published: 2018

Journal Articles

A Treatment Protocol with Imatinib and Intensive Chemotherapy for Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia Patients: A Single-Arm, Intergroup Study (EsPhALL 2010-2014)

Andrea Biondi, MD, Virginie Gandemer, MDPhD, Myriam Campbell, MD, Anders Castor, MD PhD, Rob Pieters, MD PhD, Paola De Lorenzo, PhD, Veronica Leoni, MD, Jan Stary, Gabriele Escherich, MD, Chi Kong Li, MD, Giovanni Cazzaniga, PhD, Helene Cave, PharmD, PhD, Silja Roettgers, PhD, Valentino Conter, MD, Vaskar Saha, MD PhD, Martin Schrappe, MD PhD, Maria Grazia Valsecchi, PhD

Blood (2017) 130 (Supplement 1): 97.

https://doi.org/10.1182/blood.V130.Suppl_1.97.97

Published: 2017

NARROW

Genetics of osteonecrosis in pediatric acute lymphoblastic leukemia and general populations

CELL-Derived Microparticles and Sickle CELL Disease Chronic Vasculopathy in Sub-Saharan Africa

Lack of Benefit of Extended Vincristine and Dexamethasone Pulses during Maintenance Treatment of Childhood Acute Lymphoblastic Leukemia: A Multicenter Randomized Controlled Study of Chinese Children Cancer Group (CCCG)-ALL-2015

Polymorphisms in Inflammatory Genes Modulate the Occurrence of Clinical Complications in Patients with Sickle Cell Disease

Treatment of Newly Diagnosed Moderate or Severe Chronic Graft-Versus-Host Disease with Prednisone and Everolimus (PredEver first): A Prospective Multicenter Phase IIa Study

Genetic Ancestry and Skeletal Toxicities Among Childhood Acute Lymphoblastic Leukemia Patients in the DFCI 05-001 Cohort

Studying the Determinant of Sickle Cell Disease Vasculopathy in Sub-Saharan Africa : The Biocadre Study

Hydroxyurea Exposure throughout Pregnancy in Patients with Sickle-Cell Disease : 4 Case Reports from European Non-Interventional, Multicentric, Prospective Escort-HU Study

Up-Regulation of Mir-21 and Mir-130a and Serum Leptin Levels on Leg Ulcers Development in Sickle Cell Anemia

Hypertension is a modifiable risk factor for osteonecrosis in acute lymphoblastic leukemia

Zoledronic Acid Reduces Osteonecrosis and Anti-Leukemic Efficacy in Murine Models of Acute Lymphoblastic Leukemia Therapy

Osteonecrosis in Pediatric Patients with Acute Lymphoblastic Leukemia (ALL): A Single-Center Cohort Analysis

The Effect of Asparaginase on Serum Triglycerides during Therapy for Acute Lymphoblastic Leukemia

microRNA and Severity of Sickle Cell Anemia

Amsacrine, Etoposide and Methylprednisolone As Part of the Therapy Intensification in Children with Acute Lymphoblastic Leukemia: A Retrospective Analysis in the Trial Coall 08-09

Long-Term Follow-up of SWOG S0816: Response-Adapted Therapy for Stage III/IV Hodgkin Lymphoma Demonstrates Limitations of PET-Adapted Approach

Characterizing a Population with Severe Manifestations of Sickle Cell Disease Using U.S. Real-World Evidence

Outcomes of Hip Arthroplasty in Sickle Cell Disease: A 20 Year Retrospective Review

Validation of Sickle Cell Disease Severity Score in a Cohort of Hemoglobin SC Disease Patients

A Treatment Protocol with Imatinib and Intensive Chemotherapy for Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia Patients: A Single-Arm, Intergroup Study (EsPhALL 2010-2014)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only